Sex Hormone Dependency of Diethylnitrosamine‐induced Liver Tumors in Mice and Chemoprevention by Leuprorelin
暂无分享,去创建一个
T. Asahara | Toshimasa Asahara | N. Fujimoto | Nariaki Fujimoto | Tamaki Nakatani | Goutam Roy | Akihiro Ito | A. Ito | T. Nakatani | G. Roy
[1] J. Miller,et al. Quantitative analysis of the time-dependent development of glucose-6-phosphatase-deficient foci in the livers of mice treated neonatally with diethylnitrosamine. , 1981, Cancer research.
[2] N. Drinkwater,et al. The androgen receptor and liver tumor development in mice. , 1990, Progress in clinical and biological research.
[3] J. Gustafsson,et al. On the obligatory role of the hypophysis in sexual differentiation hepatic metabolism in rats. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[4] Hiromitsu Watanabe,et al. Significance of Strain and Sex Differences in the Development of 252Cf Neutron‐induced Liver Tumors in Mice , 1992, Japanese journal of cancer research : Gann.
[5] D. Jocham. Leuprorelin Three-Month Depot in the Treatment of Advanced and Metastatic Prostate Cancer: Long-Term Follow-Up Results , 1998, Urologia Internationalis.
[6] Chien-Jen Chen,et al. Epidemiological characteristics and risk factors of hepatocellular carcinoma , 1997, Journal of gastroenterology and hepatology.
[7] T. Goldsworthy,et al. Loss of tumor-promoting activity of unleaded gasoline in N-nitrosodiethylamine-initiated ovariectomized B6C3F1 mouse liver. , 1997, Carcinogenesis.
[8] D. V. van Thiel,et al. Hormonal manipulation of human hepatocellular carcinoma. A clinical investigative and therapeutic opportunity. , 1990, Journal of hepatology.
[9] K. Rao,et al. Relevance of basophilic foci to promoting effect of sex hormones on hepatocarcinogenesis. , 1982, Carcinogenesis; a comprehensive survey.
[10] W. White,et al. Regression of rat mammary tumors effected by a gonadoliberin analog. , 1976, Cancer research.
[11] S. Mishkin,et al. The effect of several sex steroid hormones on the growth rate of three morris hepatoma tumor lines , 1989, Hepatology.
[12] M. D. Reuber. Importance of Testes in Induction of Hyperplastic Nodules, Carcinomas, and Cirrhosis of Liver in A × C Male Rats Ingesting 0.025% N-2-Fluorenyldiacetamide , 1974 .
[13] H. Shinozuka,et al. Sex steroid metabolism and receptor status in hepatic hyperplasia and cancer in rats. , 1996, Gastroenterology.
[14] J. Ward,et al. Evaluation of hepatocellular neoplasms in mice. , 1978, Journal of the National Cancer Institute.
[15] M. Zerbib,et al. [Effectiveness and tolerance of three month sustained release leuprorelin in the treatment of metastatic prostatic cancer (comparative, randomized, multicentric study]. , 1997, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.
[16] N. Nagasue,et al. Heterogeneity in androgen receptor levels and growth response to dihydrotestosterone in sublines derived from human hepatocellular carcinoma line (KYN-1). , 2008, Liver.
[17] L. Yin,et al. Influence of hypophysectomy on the biochemical effects and metabolism of aflatoxin B1 in rats. , 1973, Journal of the National Cancer Institute.
[18] M. Vaubourdolle,et al. Effect of D‐tryptophan‐6‐luteinizing hormone‐releasing hormone on the tumoral growth and plasma sex steroid levels in cirrhotic patients with hepatocellular carcinoma , 1989, Hepatology.
[19] T. Ando,et al. Leuprolide acetate prevents toxic effects of cisplatin on the kidneys and gastrointestinal tract. , 1995, Endocrine journal.
[20] W. H. Butler,et al. Aflatoxin carcinogenesis: Inhibition of liver cancer induction in hypophysectomized rats , 1969, International journal of cancer.
[21] J. Whang‐Peng,et al. Phase II study of flutamide in the treatment of hepatocellular carcinoma , 1996, Cancer.
[22] N. Drinkwater,et al. Genetic variation in liver tumor susceptibility, plasma testosterone levels, and androgen receptor binding in six inbred strains of mice. , 1989, Cancer research.
[23] T. Yashiki,et al. Regression of rat mammary tumors by a potent luteinizing hormone-releasing hormone analogue (leuprolide) administered vaginally. , 1983, Cancer research.
[24] N. Nagasue,et al. Androgen and estrogen receptors in hepatocellular carcinoma and the surrounding liver in women , 1989, Cancer.
[25] J. Korula,et al. Failure of ketoconazole as anti-androgen therapy in nonresectable primary hepatocellular carcinoma. , 1988, Journal of clinical gastroenterology.
[26] A. Yoshiki,et al. Strain specific sensitivity to diethylnitrosamine-induced carcinogenesis is maintained in hepatocytes of C3H/HeN⇔C57BL/6N chimeric mice , 1991 .
[27] A. Forbes,et al. Response to cyproterone acetate treatment in primary hepatocellular carcinoma is related to fall in free 5 alpha-dihydrotestosterone. , 1987, European journal of cancer & clinical oncology.
[28] N. Nagasue,et al. Effects of castration and androgen replacement on tumour growth of human hepatocellular carcinoma in nude mice. , 1996, Journal of hepatology.
[29] K. Rao,et al. Modifying role of partial hepatectomy and gonadectomy in ethylnitrosourea-induced hepatocarcinogenesis. , 1980, Cancer research.